(Q38424698)

3 September 2017

title

Emerging therapies for the treatment of Helicobacter pylori infections (English)

1 reference

3 September 2017

1 reference

Tomasz Z Jodlowski

1

1 reference

3 September 2017

Sum Lam

series ordinal

2

1 reference

3 September 2017

Charles R Ashby

series ordinal

3

1 reference

3 September 2017

language of work or name

English

0 references

publication date

9 October 2008

1 reference

Annals of Pharmacotherapy

3 September 2017

published in

1 reference

3 September 2017

volume

42

1 reference

3 September 2017

issue

11

1 reference

3 September 2017

page(s)

1621-1639

1 reference

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

3 September 2017

cites work

1 reference

Transfer of Campylobacter pylori and Campylobacter mustelae to Helicobacter gen. nov. as Helicobacter pylori comb. nov. and Helicobacter mustelae comb. nov., Respectively

21 January 2018

1 reference

The gastric biology of Helicobacter pylori

21 January 2018

1 reference

Helicobacter pylori persistence: biology and disease

21 January 2018

1 reference

Pathogenesis of Helicobacter pylori infection

21 January 2018

1 reference

The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases

21 January 2018

1 reference

Helicobacter pylori interacts with the human single-domain trefoil protein TFF1.

21 January 2018

1 reference

Genes of Helicobacter pylori regulated by attachment to AGS cells

21 January 2018

1 reference

The Epidemiology of Helicobacter pylori Infection

21 January 2018

1 reference

Fecal and oral shedding of Helicobacter pylori from healthy infected adults

21 January 2018

1 reference

Epidemiology of Helicobacter pylori Infection

21 January 2018

1 reference

Review article: after gastritis--an imaginary journey into a Helicobacter-free world

21 January 2018

1 reference

Concordance of Helicobacter pylori strains within families.

21 January 2018

1 reference

Genetic and transmission analysis of Helicobacter pylori strains within a family

21 January 2018

1 reference

Five-year follow-up study of mother-to-child transmission of Helicobacter pylori infection detected by a random amplified polymorphic DNA fingerprinting method

21 January 2018

1 reference

Age-specific incidence of Helicobacter pylori

21 January 2018

1 reference

Extragastric manifestations of Helicobacter pylori infection -- other Helicobacters

21 January 2018

1 reference

Helicobacter pylori eradication: novel therapy for immune thrombocytopenic purpura? A review of the literature

21 January 2018

1 reference

Helicobacter pylori interference with micronutrients and orally administered drugs: a new mechanism explaining its role in extragastric disorders.

21 January 2018

1 reference

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

21 January 2018

1 reference

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

21 January 2018

1 reference

Levofloxacin based regimens for the eradication of Helicobacter pylori

21 January 2018

1 reference

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection

21 January 2018

1 reference

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

21 January 2018

1 reference

Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis

21 January 2018

1 reference

The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection

21 January 2018

1 reference

Levofloxacin-resistant Helicobacter pylori in Hong Kong

21 January 2018

1 reference

Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients

21 January 2018

1 reference

Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance

21 January 2018

1 reference

Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure.

21 January 2018

1 reference

Moxifloxacin-based strategies for first-line treatment of Helicobacter pylori infection

21 January 2018

1 reference

Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy

21 January 2018

1 reference

Antimicrobial activity of rifabutin

21 January 2018

1 reference

Rifabutin based triple therapy for eradication of H. pylori primary and secondary resistant to tinidazole and clarithromycin

21 January 2018

1 reference

Rifabutin-based triple therapy after failure of Helicobacter pylori eradication treatment: preliminary experience.

21 January 2018

1 reference

Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.

21 January 2018

1 reference

Rifabutin-based Helicobacter pylori eradication 'rescue therapy'.

21 January 2018

1 reference

'Rescue' therapy with rifabutin after multiple Helicobacter pylori treatment failures

21 January 2018

1 reference

Efficacy of Helicobacter pylori eradication therapies: a single centre observational study

21 January 2018

1 reference

The effectiveness of rifabutin triple therapy for patients with difficult-to-eradicate Helicobacter pylori in clinical practice

21 January 2018

1 reference

Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.

21 January 2018

1 reference

Rifabutin- and furazolidone-based Helicobacter pylori eradication therapies after failure of standard first- and second-line eradication attempts in dyspepsia patients

21 January 2018

1 reference

Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients

21 January 2018

1 reference

Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection

21 January 2018

1 reference

One-week once-daily triple therapy with esomeprazole, moxifloxacin, and rifabutin for eradication of persistent Helicobacter pylori resistant to both metronidazole and clarithromycin

21 January 2018

1 reference

Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection.

21 January 2018

1 reference

The importance of the level of metronidazole resistance for the success of Helicobacter pylori eradication

21 January 2018

1 reference

Efficacy of a multistep strategy for Helicobacter pylori eradication.

21 January 2018

1 reference

Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.

21 January 2018

1 reference

A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication

21 January 2018

1 reference

Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial

21 January 2018

1 reference

Tinidazole: from protozoa to Helicobacter pylori--the past, present and future of a nitroimidazole with peculiarities

21 January 2018

1 reference

Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections

21 January 2018

1 reference

Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential

21 January 2018

1 reference

Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.

21 January 2018

1 reference

Eradication of Helicobacter pylori: are rifaximin-based regimens effective?

21 January 2018

1 reference

Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection

21 January 2018

1 reference

Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.

21 January 2018

1 reference

High efficacy of 1-week doxycycline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for Helicobacter pylori infection

21 January 2018

1 reference

Lactoferrin structure and functions

21 January 2018

1 reference

Use of bovine lactoferrin for Helicobacter pylori eradication

21 January 2018

1 reference

Use of lactoferrin for Helicobacter pylori eradication. Preliminary results

21 January 2018

1 reference

Quadruple therapy with lactoferrin for Helicobacter pylori eradication: a randomised, multicentre study.

21 January 2018

1 reference

Bovine lactoferrin is effective to suppress Helicobacter pylori colonization in the human stomach: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Interactions of plaunotol with bacterial membranes.

21 January 2018

1 reference

Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo

21 January 2018

1 reference

In vitro pharmacodynamic studies of activities of ketolides HMR 3647 (Telithromycin) and HMR 3004 against extracellular or intracellular Helicobacter pylori

21 January 2018

1 reference

Telithromycin use and spontaneous reports of hepatotoxicity

21 January 2018

1 reference

Efficacy and safety of faropenem in eradication therapy of Helicobacter pylori

21 January 2018

1 reference

Helicobacter pyloriEradication with Doxycycline—Metronidazole—Bismuth Subcitrate Triple Therapy

21 January 2018

1 reference

Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication

21 January 2018

1 reference

Helicobacter pylori eradication with either quadruple regimen with lactoferrin or levofloxacin-based triple therapy: A multicentre study

21 January 2018

1 reference

Clinical trial: levofloxacin-based quadruple therapy was inferior to traditional quadruple therapy in the treatment of resistant Helicobacter pylori infection

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1L234

1 reference

3 September 2017

1 reference